Vial

INDIVIDUAL TEST 851

DPPX Antibodies  (IgG)

Indication

Suspicion of autoimmune encephalitis

Sample material

Serum

  • Minim. volume: 0,5 mL

CSF

  • Minim. volume: 0,5 mL

Transport

Within Sweden

  • room temperature

International

  • cold

Method

Cell-based assay (CBA), Indirect immunofluorescence (IIF)

Reference interval

Serum

  • <1:10 negative

CSF

  • negative

Result

Results are reported as negative or positive. A positive result is followed by a titer (serum).

Interpretation

Analysis for anti-neuronal antibodies against DPPX in patient serum or CSF is of particular importance in differential diagnosis of encephalitis. DPPX, which is mainly produced in brain tissue, interacts with the KV4 potassium channel. DPPX is an important regulator of membrane viability in hippocampus CA1 pyramid cells. Antibodies against DPPX can lead to autoimmune encephalitis.

Antibodies against DPPX are graded as Lower-risk antibodies with a frequency of <10% of underlying cancer and a positive result yields 0 points PNS score, according to Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

References

  • Leypoldt F et al. Ann N Y Acad Sci. 2015. Autoimmune encephalopathies. PMID: 25315420
  • Dalmau J et al. Physiol Rev. 2017. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. PMID: 28298428
  • Dalmau J et al. Lancet Neurol. 2019. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. PMID: 31326280
  • Graus F et al. Neurol Neuroimmunol Neuroinflamm. 2021. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. PMID: 34006622
  • Flanagan EP et al. JAMA Neurol. 2023. Autoimmune Encephalitis Misdiagnosis in Adults. PMID: 36441519

Last updated: 2024-08-13

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 851

DPPX-antikroppar (IgG)

Indikation

Misstanke om autoimmun ecefalit

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Likvor

    li> Minim. volym: 0,5 mL

Transport

Inom Sverige

  • rumstemperatur

Internationellt

  • kylt

Metod

Cell-based assay (CBA), indirekt immunofluorescens (IIF)

Referensintervall

Serum

  • <1:10 negativt

Likvor

  • negativt

Resultat

Resultat anges som negativt eller positivt. Positivt resultat titreras (serum).

Tolkning

Analys av anti-neuronala antikroppar mot DPPX i patientserum eller likvor är av intresse vid differentialdiagnos av encefalit. DPPX som huvudsakligen produceras i hjärnvävnad, interagerar med kaliumkanalen KV4. DPPX är en viktig reglerare av membranens retbarhet i hippocampus CA1 pyramidceller. Antikroppar mot DPPX kan leda till autoimmun encefalit.

Antikroppar riktade mot DPPX bedöms vara Lower-risk antibodies med en förekomst på <10% för en underliggande cancer och positivitet ger 0 poäng i PNS score enligt Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Referenser

  • Leypoldt F et al. Ann N Y Acad Sci. 2015. Autoimmune encephalopathies. PMID: 25315420
  • Dalmau J et al. Physiol Rev. 2017. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. PMID: 28298428
  • Dalmau J et al. Lancet Neurol. 2019. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. PMID: 31326280
  • Graus F et al. Neurol Neuroimmunol Neuroinflamm. 2021. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. PMID: 34006622
  • Flanagan EP et al. JAMA Neurol. 2023. Autoimmune Encephalitis Misdiagnosis in Adults. PMID: 36441519

Senast uppdaterat: 2024-08-13

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi

Hittar du inte vad du söker? Vi kan hjälpa till